CDC. 2002d. Section 9: study summary: national survey of knowledge, attitudes, and beliefs regarding the anthrax vaccine among military personnel. Anthrax Vaccine Safety and Efficacy Plan. Atlanta: Centers for Disease Control and Prevention.

CDC. 2002e. Section 10: study summary: survey of civilian and military healthcare providers regarding the anthrax vaccine and the reporting of possible vaccine-associated adverse events. Anthrax Vaccine Safety and Efficacy Plan. Atlanta: Centers for Disease Control and Prevention.


GAO (General Accounting Office). 2000. Anthrax Vaccine: Preliminary Results of GAO’s Survey of Guard/Reserve Pilots and Aircrew Members. GAO-01-92T. Washington, D.C.: GAO.


Hubbell K. 2002. Letter to the CDC. E-mail to Clay B, Committee on Government Reform, U.S. House of Representatives, January 9.


IOM (Institute of Medicine). 2001. CDC Anthrax Vaccine Safety and Efficacy Research Program. Interim Report. Washington, D.C.: National Academy Press.

IOM. 2002. Joellenbeck LM, Zwanziger LL, Durch JS, Strom BL, eds. The Anthrax Vaccine: Is It Safe? Does It Work? Washington, D.C.: National Academy Press.


Masiello SA. 2002. Your request to supplement your biologics license application to include Hollister-Stier Laboratories LLC, Spokane, Washington, as a contract manufacturer for the filling of Anthrax Vaccine Adsorbed (AVA) has been approved. Letter to: Giri, L, BioPort Corporation, Lansing, Mich.


Wolfowitz P. 2002. Reintroduction of the Anthrax Vaccine Immunization Program (AVIP). Memorandum for Secretaries of the Military Departments; Chairman of the Joint Chiefs of Staff; Undersecretaries of Defense; Assistant Secretaries of Defense; General Counsel, Department of Defense; Inspector General, Department of Defense; Directors of Defense Agencies; Commandant of the U.S. Coast Guard. Department of Defense, Washington, D.C.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement